应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01763 中国同辐
未开盘 02-25 15:58:19
20.800
-0.140
-0.67%
最高
21.480
最低
20.700
成交量
10.64万
今开
20.920
昨收
20.940
日振幅
3.72%
总市值
66.56亿
流通市值
16.63亿
总股本
3.20亿
成交额
223.99万
换手率
0.13%
流通股本
7,997万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
附属公司补缴税款及滞纳金2.7亿元“吞噬”利润!中国同辐去年业绩预减,核医疗装备收益下降
深圳商报·读创 · 02-21
附属公司补缴税款及滞纳金2.7亿元“吞噬”利润!中国同辐去年业绩预减,核医疗装备收益下降
中国同辐盈警后一度跌超7%
每日经济新闻 · 02-13
中国同辐盈警后一度跌超7%
中国同辐:2025年归母净利润预降约20%至25%
财中社 · 02-12
中国同辐:2025年归母净利润预降约20%至25%
中国同辐:预计2025年度净利润6.11亿元至6.55亿元 同比减少约25...
新浪财经 · 02-12
中国同辐:预计2025年度净利润6.11亿元至6.55亿元 同比减少约25...
中国同辐股份有限公司2025年度营收约人民币69.79亿元至72.06亿元,净利润约人民币3.02亿元至3.22亿元
公告速递 · 02-12
中国同辐股份有限公司2025年度营收约人民币69.79亿元至72.06亿元,净利润约人民币3.02亿元至3.22亿元
中国同辐(01763)发盈警 预计年度股东应占利润约3.02亿元至3.22亿元 同比减少约20%至25%
智通财经 · 02-12
中国同辐(01763)发盈警 预计年度股东应占利润约3.02亿元至3.22亿元 同比减少约20%至25%
中国同辐02月12日遭主力抛售86.6万元
市场透视 · 02-12
中国同辐02月12日遭主力抛售86.6万元
中国同辐(01763)2026年1月无新增发行或股份变动
公告速递 · 02-02
中国同辐(01763)2026年1月无新增发行或股份变动
中国同辐01月30日主力净流入39.7万元 散户资金抛售
市场透视 · 01-30
中国同辐01月30日主力净流入39.7万元 散户资金抛售
中国同辐(01763):原子高科首次实现放射性核素锗-68的国产规模化制备
智通财经 · 01-29
中国同辐(01763):原子高科首次实现放射性核素锗-68的国产规模化制备
中国同辐01月22日主力净流出59.8万元 散户资金买入
市场透视 · 01-22
中国同辐01月22日主力净流出59.8万元 散户资金买入
中国同辐01月16日主力净流入41.8万元 散户资金抛售
市场透视 · 01-16
中国同辐01月16日主力净流入41.8万元 散户资金抛售
中国同辐01月12日主力净流入89.0万元 散户资金抛售
市场透视 · 01-12
中国同辐01月12日主力净流入89.0万元 散户资金抛售
中国同辐01月06日遭主力抛售45.3万元
市场透视 · 01-06
中国同辐01月06日遭主力抛售45.3万元
中国同辐盘中异动 大幅上涨5.45%报21.300港元
市场透视 · 01-02
中国同辐盘中异动 大幅上涨5.45%报21.300港元
中国同辐子公司补缴税款2.71亿元
中国经营报 · 01-01
中国同辐子公司补缴税款2.71亿元
中国同辐(01763)附属公司海得威已完成税款缴纳
智通财经 · 2025-12-31
中国同辐(01763)附属公司海得威已完成税款缴纳
中国同辐12月31日遭主力抛售36.8万元
市场透视 · 2025-12-31
中国同辐12月31日遭主力抛售36.8万元
中国同辐12月29日主力净流出388.1万元 散户资金买入
市场透视 · 2025-12-29
中国同辐12月29日主力净流出388.1万元 散户资金买入
中国同辐(01763)附属公司中核海得威BNCT硼药获批临床
智通财经 · 2025-12-19
中国同辐(01763)附属公司中核海得威BNCT硼药获批临床
暂无数据
公司概况
公司名称:
中国同辐
所属市场:
SEHK
上市日期:
--
主营业务:
中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪,以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。
发行价格:
--
{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":20.8,"timestamp":1772006299859,"preClose":20.94,"halted":0,"volume":106400,"delay":0,"changeRate":-0.00668576886341932,"floatShares":79968800,"shares":320000000,"eps":1.271262,"marketStatus":"未开盘","change":-0.14,"latestTime":"02-25 15:58:19","open":20.92,"high":21.48,"low":20.7,"amount":2239940,"amplitude":0.037249,"askPrice":20.92,"askSize":600,"bidPrice":20.8,"bidSize":200,"shortable":0,"etf":0,"ttmEps":1.452966,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":0,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":20.94,"dividendRate":0.020488,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"volumeRatio":0.444962,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763/tweets","defaultTab":"tweets","newsList":[{"id":"2613521256","title":"附属公司补缴税款及滞纳金2.7亿元“吞噬”利润!中国同辐去年业绩预减,核医疗装备收益下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2613521256","media":"深圳商报·读创","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613521256?lang=zh_cn&edition=full","pubTime":"2026-02-21 13:56","pubTimestamp":1771653403,"startTime":"0","endTime":"0","summary":"附属公司补缴税款及滞纳金2.7亿元“吞噬”利润!中国同辐去年业绩预减,核医疗装备收益下降","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602213651789152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159891","01763","BK1222"],"gpt_icon":0},{"id":"2611135561","title":"中国同辐盈警后一度跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611135561","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611135561?lang=zh_cn&edition=full","pubTime":"2026-02-13 15:00","pubTimestamp":1770966050,"startTime":"0","endTime":"0","summary":"每经AI快讯,2月13日,中国同辐(01763.HK)盈警后一度跌超7%,截至发稿跌6.54%,报20.3港元,成交额1147.11万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602133650351990.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"e72ce594d163813446b6a4d8cf9cfd10","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602133650351990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2610445939","title":"中国同辐:2025年归母净利润预降约20%至25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610445939","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610445939?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:10","pubTimestamp":1770891010,"startTime":"0","endTime":"0","summary":"2月12日,中国同辐(01763)发布公告,公司预计2025年收益约69.79亿元至72.06亿元,同比下降约5%至8%;净利润预计为6.11亿元至6.55亿元,同比下降约25%至30%;归母净利润约3.02亿元至3.22亿元,同比下降约20%至25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602123649342238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01763"],"gpt_icon":0},{"id":"2611042649","title":"中国同辐:预计2025年度净利润6.11亿元至6.55亿元 同比减少约25...","url":"https://stock-news.laohu8.com/highlight/detail?id=2611042649","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611042649?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:58","pubTimestamp":1770890280,"startTime":"0","endTime":"0","summary":"截至目前,公司经营运作正常,2025年度收益减少主要由于集团的核医疗装备分部收益下降,利润减少主要由于公司附属公司深圳市中核海得威生物科技有限公司补缴税费及滞纳金影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212180038a6f2e554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212180038a6f2e554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763"],"gpt_icon":0},{"id":"1107743382","title":"中国同辐股份有限公司2025年度营收约人民币69.79亿元至72.06亿元,净利润约人民币3.02亿元至3.22亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107743382","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107743382?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:52","pubTimestamp":1770889934,"startTime":"0","endTime":"0","summary":"本季度信息\n根据公告,中国同辐股份有限公司预计,截至2025年12月31日止年度,营收约人民币69.79亿元至人民币72.06亿元,同比减少约5%至8%;净利润约人民币3.02亿元至人民币3.22亿元,同比减少约20%至25%。\n公司表示,目前经营运作正常。营业收入下滑主要来自核医疗装备业务板块的收益下降;净利润减少则受到旗下深圳市中核海得威生物科技有限公司补缴税费及滞纳金的影响。\n业务分项\n公告显示,核医疗装备分部营收出现下滑,进一步拖累了整体营收表现。该分部业绩下降与市场环境及补缴税费事项共同影响了公司整体利润水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"gpt_icon":0},{"id":"2610786949","title":"中国同辐(01763)发盈警 预计年度股东应占利润约3.02亿元至3.22亿元 同比减少约20%至25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610786949","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610786949?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:51","pubTimestamp":1770889874,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国同辐(01763)发布公告,根据对本集团截至2025年12月31日止年度的未经审核综合管理账目及现时可得数据之初步审阅,预期与2024年同期相比:收益预计约人民币69.79亿元至人民币72.06亿元,同比减少约5%至8%;净利润预计约人民币6.11亿元至人民币6.55亿元,同比减少约25%至30%;本公司权益股东应占年内利润预计约人民币3.02亿元至人民币3.22亿元,同比减少约20%至25%。截至目前,公司经营运作正常,2025年度收益减少主要由于本集团的核医疗装备分部收益下降,利润减少主要由于本公司附属公司深圳市中核海得威生物科技有限公司补缴税费及滞纳金影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"中国同辐(01763)发盈警 预计年度股东应占利润约3.02亿元至3.22亿元 同比减少约20%至25%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2611904238","title":"中国同辐02月12日遭主力抛售86.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611904238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611904238?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:15","pubTimestamp":1770884130,"startTime":"0","endTime":"0","summary":"02月12日, 中国同辐股价跌0.73%,报收21.72元,成交金额335.9万元,换手率0.19%,振幅1.28%,量比0.99。中国同辐今日主力资金净流出86.6万元,上一交易日主力净流出84.9万元。该股近5个交易日上涨3.04%,主力资金累计净流出89.2万元;近20日主力资金累计净流出217.8万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212161711a49b8bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212161711a49b8bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"1151931588","title":"中国同辐(01763)2026年1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1151931588","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151931588?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:41","pubTimestamp":1770021703,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司于2026年2月2日向香港联交所提交的月报显示,报告期为2026年1月,公司股本维持不变,未有新增发行或回购活动。\n根据月报,公司已发行H股数量为79,968,800股,内资股数量为239,906,100股,两类股份在2026年1月均无增减变动。公司法定注册股本保持在人民币319,874,900元,其中H股面值人民币1元,内资股面值同为人民币1元。\n公司在月报中确认已遵守香港联交所《上市规则》及相关法律法规,并由联席公司秘书王仓忍代表董事会签署。至此,公司截至2026年1月31日的股份结构及股本状况保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"gpt_icon":0},{"id":"2607025643","title":"中国同辐01月30日主力净流入39.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607025643?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:15","pubTimestamp":1769760918,"startTime":"0","endTime":"0","summary":"01月30日, 中国同辐股价涨0.64%,报收21.90元,成交金额285.5万元,换手率0.17%,振幅3.40%,量比0.71。中国同辐今日主力资金净流入39.7万元,上一交易日主力净流出87.8万元。该股近5个交易日下跌0.90%,主力资金累计净流出23.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入269.0万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130161607a6bf30e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130161607a6bf30e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2607082821","title":"中国同辐(01763):原子高科首次实现放射性核素锗-68的国产规模化制备","url":"https://stock-news.laohu8.com/highlight/detail?id=2607082821","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607082821?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:29","pubTimestamp":1769689791,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国同辐 公布,近日,原子高科股份有限公司利用30MeV质子回旋加速器,首次实现放射性核素锗-68的国产规模化制备,各项指标均符合欧美商业化产品核素要求,这标志着我国正式具备自主、稳定的锗-68规模化生产能力,为肿瘤患者精准诊断治疗带来福音。目前,世界上仅有少数国家攻克了锗-68的规模化制备技术。锗-68是放射性核素镓-68的母体核素,通过衰变生成镓-68。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2605844014","title":"中国同辐01月22日主力净流出59.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2605844014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605844014?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:16","pubTimestamp":1769069766,"startTime":"0","endTime":"0","summary":"01月22日, 中国同辐股价跌1.73%,报收21.64元,成交金额334.4万元,换手率0.19%,振幅2.18%,量比1.41。中国同辐今日主力资金净流出59.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌3.48%,主力资金累计净流出18.1万元;近20日主力资金累计净流出271.7万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122162507a4490d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122162507a4490d28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2604133489","title":"中国同辐01月16日主力净流入41.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2604133489","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604133489?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:15","pubTimestamp":1768551357,"startTime":"0","endTime":"0","summary":"01月16日, 中国同辐股价涨0.36%,报收22.50元,成交金额247.1万元,换手率0.14%,振幅2.85%,量比0.45。中国同辐今日主力资金净流入41.8万元,上一交易日主力净流出53.8万元。该股近5个交易日下跌4.34%,主力资金累计净流入130.5万元;近20日主力资金累计净流出292.8万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116162329a7221d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116162329a7221d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2603523112","title":"中国同辐01月12日主力净流入89.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603523112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603523112?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205759,"startTime":"0","endTime":"0","summary":"01月12日, 中国同辐股价涨1.28%,报收23.82元,成交金额523.2万元,换手率0.27%,振幅2.89%,量比0.60。中国同辐今日主力资金净流入89.0万元,上一交易日主力净流出0万元。该股近5个交易日上涨1.88%,主力资金累计净流入305.2万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出384.5万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112163126a4b9c1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112163126a4b9c1c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2601827417","title":"中国同辐01月06日遭主力抛售45.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601827417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601827417?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687341,"startTime":"0","endTime":"0","summary":"01月06日, 中国同辐股价跌2.31%,报收22.84元,成交金额488.0万元,换手率0.27%,振幅3.42%,量比0.53。中国同辐今日主力资金净流出45.3万元,连续5日净流出,上一交易日主力净流出8.2万元。该股近5个交易日上涨12.51%,主力资金累计净流出604.0万元;近20日主力资金累计净流出848.7万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161911a6f9723f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161911a6f9723f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2600906857","title":"中国同辐盘中异动 大幅上涨5.45%报21.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600906857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600906857?lang=zh_cn&edition=full","pubTime":"2026-01-02 10:21","pubTimestamp":1767320475,"startTime":"0","endTime":"0","summary":"2026年01月02日早盘10时21分,中国同辐股票出现波动,股价快速上涨5.45%。截至发稿,该股报21.300港元/股,成交量16.6万股,换手率0.21%,振幅6.49%。中国同辐股票所在的药品行业中,整体涨幅为0.60%。其相关个股中,艾美疫苗、中国医疗集团、中国同辐涨幅较大,振幅较大的相关个股有宝济药业-B、英硅智能、中智药业,振幅分别为15.54%、10.93%、8.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102102115953be693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102102115953be693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2600808032","title":"中国同辐子公司补缴税款2.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600808032","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600808032?lang=zh_cn&edition=full","pubTime":"2026-01-01 20:30","pubTimestamp":1767270643,"startTime":"0","endTime":"0","summary":"2025年12月31日,港股上市公司中国同辐(1763.HK)披露,旗下非全资附属公司深圳市中核海得威生物科技有限公司(以下简称“海得威”)近日补缴2024年企业所得税、增值税等1.88亿元及滞纳金,合计为2.71亿元。中国同辐方面称,该事项将影响中国同辐2025年利润约1.3亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601013607492793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2595201317","title":"中国同辐(01763)附属公司海得威已完成税款缴纳","url":"https://stock-news.laohu8.com/highlight/detail?id=2595201317","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595201317?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:40","pubTimestamp":1767174003,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国同辐 发布公告,于2025年12月31日,经相关主管机关认定,公司非全资附属公司深圳市中核海得威生物科技有限公司(海得威)近日应补缴2021年1月1日至2024年12月31日企业所得税、增值税等税款人民币1.88亿元及滞纳金合计人民币2.71亿元,主要涉及海得威前述年度期间的销售费用、存货非正常损失等,该事项不涉及行政处罚。截至本公告日期,海得威已完成该税款缴纳。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2600608822","title":"中国同辐12月31日遭主力抛售36.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600608822","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600608822?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:15","pubTimestamp":1767168957,"startTime":"0","endTime":"0","summary":"12月31日, 中国同辐股价跌0.10%,报收20.20元,成交金额222.1万元,换手率0.14%,振幅1.78%,量比0.62。中国同辐今日主力资金净流出36.8万元,连续3日净流出,上一交易日主力净流出48万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为60.00%,平均跌幅为2.52%。该股近5个交易日下跌2.88%,主力资金累计净流出472.9万元;近20日主力资金累计净流出759.9万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231162203a6e4b7de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231162203a6e4b7de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2595735510","title":"中国同辐12月29日主力净流出388.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2595735510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595735510?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996145,"startTime":"0","endTime":"0","summary":"12月29日,中国同辐股价收平报20.30元,成交金额760.1万元,换手率0.47%,振幅3.94%,量比4.07。中国同辐今日主力资金净流出388.1万元,上一交易日主力净流出0万元。该股近5个交易日下跌1.93%,主力资金累计净流出388.1万元;近20日主力资金累计净流出675.1万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161940a6dc374c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161940a6dc374c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2592741169","title":"中国同辐(01763)附属公司中核海得威BNCT硼药获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2592741169","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592741169?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:03","pubTimestamp":1766145788,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国同辐 发布公告,近日,国家药品监督管理局药品审评中心官网信息显示公司附属公司深圳市中核海得威生物科技有限公司自主研发的2.2类改良新药“注射用硼[10B]法仑”临床试验申请获批。此外,中核海得威“注射用硼[10B]法仑”临床试验申请获批标志着中核海得威BNCT药械协同研发领域取得突破性成果,正式迈入临床转化新阶段,为“健康中国”战略下的精准肿瘤治疗注入核科技新动能,为全球肿瘤治疗贡献“中国方案”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01763"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":-0.0772},{"period":"3month","weight":-0.0494},{"period":"6month","weight":0.2521},{"period":"1year","weight":0.8494},{"period":"ytd","weight":0.0297}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0},{"period":"3month","weight":0.0316},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪,以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.035423},{"month":2,"riseRate":0.5,"avgChangeRate":0.040163},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.034143},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.013249},{"month":5,"riseRate":0.571429,"avgChangeRate":0.015374},{"month":6,"riseRate":0.571429,"avgChangeRate":0.05564},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.022851},{"month":8,"riseRate":0.5,"avgChangeRate":0.038573},{"month":9,"riseRate":0.125,"avgChangeRate":-0.029064},{"month":10,"riseRate":0.625,"avgChangeRate":-0.037438},{"month":11,"riseRate":0.75,"avgChangeRate":0.064344},{"month":12,"riseRate":0.5,"avgChangeRate":0.001691}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}